| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.741 | 16.520 | 9.804 | 10.530 | 21.500 | 21.619 | 20.460 | 19.740 | 35.989 | 21.103 |
| Total Income - EUR | 25.743 | 16.520 | 9.809 | 10.530 | 21.510 | 21.619 | 20.532 | 21.581 | 36.782 | 24.583 |
| Total Expenses - EUR | 17.748 | 16.166 | 8.910 | 10.386 | 21.696 | 30.069 | 15.316 | 16.167 | 14.845 | 12.064 |
| Gross Profit/Loss - EUR | 7.995 | 355 | 899 | 145 | -185 | -8.451 | 5.216 | 5.413 | 21.936 | 12.519 |
| Net Profit/Loss - EUR | 7.223 | 24 | 801 | 40 | -400 | -8.731 | 4.599 | 4.779 | 18.931 | 10.747 |
| Employees | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biomediu-Engineering Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 801 | 502 | 182 | 615 | 0 | 1.056 | 1.754 | 3.176 | 3.978 | 18.010 |
| Current Assets | 18.703 | 16.441 | 12.579 | 11.528 | 13.170 | 6.586 | 8.543 | 6.903 | 20.268 | 11.753 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 11.666 | 11.031 | 12.251 | 11.130 | 9.974 | 4.536 | 2.169 | -717 | 897 | 926 |
| Cash | 7.037 | 5.409 | 328 | 399 | 3.196 | 2.049 | 6.374 | 7.619 | 19.371 | 10.827 |
| Shareholders Funds | 14.730 | 580 | 1.372 | 1.386 | 959 | -7.791 | -3.019 | 1.751 | 20.677 | 27.348 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.775 | 16.363 | 11.389 | 10.757 | 12.211 | 15.432 | 13.315 | 8.327 | 3.569 | 2.416 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Biomediu-Engineering Srl